Marrow
Genomics · Genetic Reports · Precision Wellness

Eye Health Report

Personalized Genetic Report
VisionEye Health
Sample ClientReport date: 29 July 2026
Genomics · Genetic Reports · Precision Wellness
Marrow Health Laboratories
Marrow
Accession #: MRW-26-0535DE
Report type: Summary Report
Report status: FINAL

Specimen and client information

Client
Sample Client
Specimen type
Buccal (cheek) swab
Date reported
29 July 2026
Accession
MRW-26-0535DE
Panel
Eye Health Report
Results scored
22
Need attention
5
Report
Summary Report

What this report covers

Vision · Eye Health

About this report

This report reads your DNA and sorts every result into one of five plain-language groups, so you can see at a glance what deserves attention and what does not. Nothing here is a diagnosis. A flagged result means your genetics place you above or below the average person for that trait — a reason to ask a question, not a reason to worry.

What each result group means

Worth a conversation with your doctor
These came back with a higher genetic predisposition than most people. That is not a diagnosis — it means these are the ones worth raising at your next appointment.
Running above the typical range
Your genetics point to these sitting higher than average. Often useful to know, sometimes worth monitoring.
Running below the typical range
Your genetics point to these sitting lower than average. Same idea — context, not alarm.
Working in your favour
Good news. Your genetics look protective or better than average here.
In line with most people
Nothing unusual. These were tested and came back typical — worth having on record.

Your results at a glance

How to read this. A result being flagged does not mean you have a condition — it means your genetics put you above or below the average person for that trait. Of the 22 results here, 5 came back worth discussing with a clinician and 5 came back in your favour. Bring this document to your appointment.

What this package looks at

Eye Health — Maintaining healthy vision is vital for overall well-being and quality of life. Genetics play a significant role in determining your susceptibility to various eye health problems, including common vision issues like cataracts, glaucoma, and macular degeneration. In addition to these, certain genetic

What you can actually do

These are ordered by how closely they relate to your flagged results — not generic health advice. Marrow does not prescribe, dose, or tell you to take anything. Diet and lifestyle changes are listed first because they are yours to make. Anything you would swallow is listed separately, by name only, as something to raise with a clinician who knows your history and your medications.

Changes you can make yourself

1
Diaphragmatic Breathing10 minutes

TA hand on your chest and the other on your belly.

Relates to: Glaucoma
relevance
2
Sleep for 7+ Hours

Ensure you allocate enough time in your schedule to achieve a minimum of 7 hours of sleep each night.

Relates to: Glaucoma, Eye Inflammation
relevance

Worth asking your clinician about

These came up in the research behind your flagged results. They are listed by name so you can ask about them. Marrow is not recommending them, and gives no dose. Supplements interact with prescription medication and with each other — that conversation belongs with your clinician.

1
Methylfolate
Relates to: Retinal Vein Occlusion
relevance
2
Forskolin
Relates to: Glaucoma
relevance
3
Vitamin C
Relates to: Cataracts
relevance
4
Rutin
Relates to: Glaucoma, Retinal Vein Occlusion
relevance
5
Citicoline (CDP Choline)
Relates to: Glaucoma
relevance
6
Palmitoylethanolamide (PEA)
Relates to: Glaucoma
relevance
7
Dietary Vitamin E
Relates to: Cataracts
relevance
8
Turmeric
Relates to: Eye Inflammation, Retinal Vein Occlusion
relevance
9
Saffron
Relates to: Glaucoma
relevance
10
Ginkgo
Relates to: Glaucoma
relevance
11
Alpha-GPC Choline
Relates to: Glaucoma
relevance
12
Blackcurrant Supplement
Relates to: Glaucoma
relevance

Your headline findings

Of the 22 results in this package, these 5 came back furthest from the population average. Each one below explains what it is, where you sit, and which report it came from. Start here.

Eye StyeMore likely
Higher predisposition than 99% of people
Your risk is greater than 99% of the population ng treatments can help alleviate symptoms and lower than 1% of the population.

What this actually is

Styes can develop eyelashes become factors include: Poor hygiene: transfer Makeup use: remove makeup blockages.

Eye irritation: hygiene or Chronic are more prone Most styes heal on However, the and speed up Warm affected eyelid help the stye Massage: Gently may help applying warm Keep it clean: keeping it Avoid makeup makeup or further relievers can Preventive measures removing makeup the eyes with significantly eye infections.

From your Eye Health report
Retinal Vein OcclusionMore likely
Higher predisposition than 90% of people
Your risk is greater than 90% of the population and lower than 10% of the population.

What this actually is

Retinal Vein Treatment for underlying risk from the blockage. injections of vision, laser reduce inflammation.

Ask your clinician about

  • Methylfolate
  • Rutin
  • Turmeric

Named only. Marrow gives no dose and does not recommend these.

From your Eye Health report
Eye InflammationMore likely
More likely to have uveitis based on 3,409 genetic variants we looked at
Your risk is greater than 84% of the population and lower than 16% of the population.

What this actually is

The management of uveitis involves addressing both the inflammation and the underlying cause if identified.

Typical treatments include corticosteroids to reduce the inflammation and drugs that manage the immune system's response.

Careful monitoring by an ophthalmologist is critical to prevent complications such as glaucoma, cataracts, and macular edema, all of which could lead to loss of vision.

What you can do

  • Sleep for 7+ Hours
    Ensure you allocate enough time in your schedule to achieve a minimum of 7 hours of sleep each night.

Ask your clinician about

  • Turmeric
  • Curcumin

Named only. Marrow gives no dose and does not recommend these.

From your Eye Health report
GlaucomaMore likely
More likely to get glaucoma based on 1,049,432 genetic variants we looked at
Your risk is greater than 78% of the population and lower than 22% of the population.

What this actually is

Other risk factors include internal eye pressure, age, race, eye injury, and high corticosteroid use.

About 3 million Americans have glaucoma, and about 2.5% of the world's population.

Symptoms include loss of peripheral or central vision, headache, eye pain, halos, eye redness, and nausea.

Ask your clinician about

  • Forskolin
  • Rutin
  • Citicoline (CDP Choline)

Named only. Marrow gives no dose and does not recommend these.

From your Eye Health report
CataractsMore likely
More likely to have a cataract based on 870,950 genetic variants we looked at

What this actually is

Key Takeaways: About 25-60% of differences in people's chances of having cataracts may be due to genetics.

Risk factors: age, diabetes, smoking, obesity, high blood pressure, excessive sunlight exposure, and eye injury.

About 96 million people in the world are blind, and just over half of those are due to cataracts.

Ask your clinician about

  • Vitamin C
  • Dietary Vitamin E
  • Dietary Vitamin E

Named only. Marrow gives no dose and does not recommend these.

From your Eye Health report

Where your genetics are working for you

Not everything in a genetic report is a warning. These came back protective or better than average.

Allergic Eye IrritationLess likely
Less likely to have allergic eye disease based on 740 genetic variants we looked at
Your risk is greater than 2% of the population and lower than 98% of the population.

What this actually is

Management of allergic eye disease often involves a combination of treatments and preventive measures.

If symptoms persist or worsen, it’s important to consult a healthcare provider to ensure appropriate management and avoid complications.

Identifying and minimizing exposure to the allergens that trigger symptoms is the most important preventive measure.

From your Eye Health report
Iris InflammationLess likely
Less likely to have iritis based on 55 genetic variants we looked at
Your risk is greater than 11% of the population and lower than 89% of the population.

What this actually is

The causes of iritis are varied and can include infectious diseases, such as syphilis or herpes zoster, as well as non-infectious systemic inflammatory conditions like ankylosing spondylitis, sarcoidosis, or inflammatory bowel disease.

Treatment for iritis is targeted at reducing the inflammation and managing any underlying cause that can be identified.

This often involves the use of corticosteroid eye drops to control inflammation and other medication to dilate the pupil and relieve pain.

From your Eye Health report
Double VisionLess likely
Less likely to have diplopia based on 989,301 genetic variants we looked at
Your risk is greater than 16% of the population and lower than 84% of the population.

What this actually is

Double vision can of life, leading to performing everyday some cases, double underlying systemic disease, controlling the eye Therefore, it is when experiencing appropriate eye exercises, or underlying cause.

From your Eye Health report

Everything else that came back

The remaining results, grouped by what they mean. Every one of these is explained in full — with the genes and variants behind it — in the technical version of this report.

Working in your favour  (2)
  • Optic Nerve Inflammation — Less likely, 19th percentile
  • Retinitis Pigmentosa — Less likely
In line with most people  (12)
  • Aging Eyes — Typical likelihood, 77th percentile
  • Vision Loss — Typical likelihood, 67th percentile
  • Involuntary Eye Movements — Typical likelihood, 61th percentile
  • Age-Related Macular Degeneration — Typical likelihood, 44th percentile
  • Lazy Eye — Typical likelihood, 37th percentile
  • Pink Eye — Typical likelihood, 33th percentile
  • Retinal Detachment — Typical likelihood, 32th percentile
  • Eyelid Inflammation — Typical likelihood, 20th percentile
  • Nearsightedness — Typical likelihood
  • Keratoconus — Typical likelihood
  • Dry Eyes — Typical likelihood
  • Eye Cancer — Typical likelihood

What to do with this

Genetics is a predisposition, not a verdict. The single most useful thing you can do with this document is take it to a clinician and talk through the flagged findings — especially any that line up with symptoms you already have or conditions that run in your family. Nothing here changes: your DNA is the same at 60 as it is today, so this report does not expire.

Methodology

Genotyping was performed on DNA extracted from a buccal (cheek) swab using a genome-wide array. Results are derived from peer-reviewed genome-wide association data and, where applicable, published clinical guidelines. Each report was scored independently against its own reference set. Percentile figures describe where your result sits relative to a reference population.

Limitations

This is a laboratory-developed test. It has not been cleared or approved by the U.S. Food and Drug Administration. Genotyping does not detect all variants in the genes assessed; the absence of a flagged result does not exclude risk. Predisposition is probabilistic and is modified by environment, lifestyle, ancestry and family history. Results must be interpreted by a qualified healthcare professional and must not be used alone to diagnose, treat, or alter any medication regimen. Marrow does not recommend, prescribe, or dose any supplement or medication.

Performing laboratory & attestation
Performing laboratoryGene by Gene, Ltd.
Laboratory address1445 North Loop West, Suite 760, Houston, TX 77008
CLIA certificationCLIA #45D1102202
CAP accreditationCAP #7212851 · accredited through 7 October 2027
Laboratory DirectorFeng Zhou, PhD, MB(ASCP)
Specimen typeBuccal (cheek) swab — genomic DNA
AccessionMRW-26-0535DE
Date reported29 July 2026

This specimen was tested at Gene by Gene, Ltd., 1445 North Loop West, Suite 760, Houston, TX 77008, under CLIA #45D1102202 and CAP #7212851. Laboratory Director: Feng Zhou, PhD, MB(ASCP). Marrow Health is not a clinical laboratory and does not perform testing; Marrow prepares and delivers this report from data produced by the performing laboratory named above. Report generated 29 July 2026 · Accession MRW-26-0535DE · © 2026 Marrow Health.